CAS No.951382-34-6 Pharmaceutical Intermediates
Ipragliflozin L-Proline Overview
Ipragliflozin L-Proline is a novel sodium-glucose co-transporter 2 (SGLT2) inhibitor that plays a vital role in the treatment of type 2 diabetes. By inhibiting the reabsorption of glucose by the kidneys, Ipragliflozin promotes the excretion of excess glucose in the urine, thereby lowering blood sugar levels. This innovative compound not only helps control blood sugar, but also supports weight loss and cardiovascular health, making it a versatile option for diabetes treatment.
product detail
|
CAS No. |
951382-34-6 |
|
EINECS |
/ |
|
Formula |
C21H21FO5S.C5H9NO2 |
|
Molecular Weight |
519.58 |
|
Appearance |
White or off white powder |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
Application in the pharmaceutical industry
·
In summary, Ipragliflozin L-Proline is a breakthrough product that offers significant benefits to the pharmaceutical industry. With its high purity, excellent solubility, and proven efficacy, it is an essential ingredient in the development of effective diabetes therapies. Partner with us to take advantage of the benefits of Ipragliflozin L-Proline and enhance your drug supply!



